Volume 8.46 | Nov 20

ESC & iPSC News 8.46 November 20, 2013
ESC & iPSC News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ESC & iPSC News on Twitter
Directed Differentiation of Human Pluripotent Cells to Ureteric Bud Kidney Progenitor-Like Cells
Researchers report on the differentiation of human pluripotent cells into ureteric-bud-committed renal progenitor-like cells. The generated cells demonstrated rapid and specific expression of renal progenitor markers on 4-day exposure to defined media conditions. [Nat Cell Biol] Abstract | Press Release
STEMdiff™ Definitive Endoderm Kit For Easy, Standardized hPSC Differentiation
PUBLICATIONS ( Ranked by impact factor of the journal)
The let-7/LIN-41 Pathway Regulates Reprogramming to Human Induced Pluripotent Stem Cells by Controlling Expression of Prodifferentiation Genes
Scientists showed that the let-7 family of microRNAs acts as an inhibitory influence on the reprogramming process through a regulatory pathway involving prodifferentiation factors, including EGR1. Inhibiting let-7 in human cells promotes reprogramming to a comparable extent to c-MYC when combined with OCT4, SOX2, and KLF4, and persistence of let-7 inhibits reprogramming. [Cell Stem Cell] Abstract | Graphical Abstract

A Fully Defined and Scalable 3D Culture System for Human Pluripotent Stem Cell Expansion and Differentiation
Researchers report a simple, defined, efficient, scalable, and good manufacturing practice-compatible 3D culture system for human pluripotent stem cells expansion and differentiation. [Proc Natl Acad Sci USA] Abstract

Analysis of DNA Methylation Reveals a Partial Reprogramming of the Müller Glia Genome during Retina Regeneration
Because somatic cell reprogramming during induced pluripotent stem cell generation is accompanied by changes in DNA methylation, especially in pluripotency factor gene promoters, scientists aimed to determine whether DNA methylation changes also underlie Müller glia reprogramming following retinal injury. [Proc Natl Acad Sci USA] Abstract

Oct4 Is Required ~E7.5 for Proliferation in the Primitive Streak
Using a tamoxifen-inducible Cre recombinase and floxed alleles of Oct4, scientists investigated the effect of depleting Oct4 in mouse embryos between the pre-streak and headfold stages, ~E6.0-E8.0, when Oct4 is found in dynamic patterns throughout the embryonic compartment of the mouse egg cylinder. [PLoS Genet] Full Article

RNAi-Dependent and Independent Control of LINE1 Accumulation and Mobility in Mouse Embryonic Stem Cells
Scientists showed that Dicer- and Ago2-dependent RNAi restricts long-interspersed elements-1 accumulation and retrotransposition in undifferentiated mouse embryonic stem cells, derived from blastocysts. [PLoS Genet] Full Article

Comparative Receptor Tyrosine Kinase Profiling Identifies a Novel Role for AXL in Human Stem Cell Pluripotency
Researchers present the first detailed and distinct repertoire of receptor tyrosine kinases (RTKs) characteristic for human pluripotent stem cell pluripotency by determining both the expression and phosphorylation profiles of RTKs in human embryonic stem cells and human induced pluripotent stem cells using RT-PCR with degenerate primers that target conserved tyrosine kinase domains and phospho-RTK array, respectively. [Hum Mol Genet] Abstract

Dual Functions of Hypoxia Inducible Factor-1 Alpha for the Commitment of Mouse Embryonic Stem Cells Toward a Neural Lineage
Investigators demonstrated that the oxygen-sensitive hypoxia-inducible transcription factor, Hif-1α, is an essential regulator for neural commitment of embryonic stem cells. [Stem Cell Dev] Abstract

EDA-Containing Fibronectin Increases Proliferation of Embryonic Stem Cells
The authors investigated if the fibronectin isoform that contains the extra domain A (FN EDA+) increased proliferation of mouse and human embryonic stem cells. They analyzed cell proliferation using conditioned media produced by different mouse embryonic fibroblast lines genetically engineered to express FN constitutively including or excluding the EDA domain, and in media supplemented with recombinant peptides containing or not the EDA. [PLoS One] Full Article

MiR-223 Regulates Human Embryonic Stem Cell Differentiation by Targeting the Insulin-Like Growth Factor Receptor/Akt Signaling Pathway
Levels of MicroRNA-223 (miR-223) were detected in differentiated versus undifferentiated human embryonic stem cells (hESCs). In addition, proliferation, apoptosis, and differentiation were assayed in these two hESC populations and were compared in the presence of exogenous miR-223 and miR-223 inhibitor. [PLoS One] Full Article

The Presenilin-1 ΔE9 Mutation Results in Reduced γ-Secretase Activity, but Not Total Loss of PS1 Function, in Isogenic Human Stem Cells
Scientists used isogenic euploid human induced pluripotent stem cell lines to generate and study an allelic series of Presenilin 1 (PS1) mutations, including heterozygous null mutations and homozygous and heterozygous familial Alzheimer’s disease PS1 mutations. [Cell Rep]
Full Article | Graphical Abstract | Press Release

Use TeSR-E7 to generate iPS cells with high quality colony morphology for easy identification and rapid subcloning. Request your sample.
Induced Neural Stem Cells: Methods of Reprogramming and Potential Therapeutic Applications
This review focuses on reported reprogramming techniques and innovative techniques that can be further explored in induced neural stem cells (iNSCs), as well as on the criteria for the phenotypic characterization of iNSCs and their use in developing novel therapeutic strategies for neurological diseases. [Prog Neurobiol] Abstract

Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.
Multipotent Stem Cell Proteins Support Soft Tissue Regeneration
Through its proprietary technology process that simulates the conditions of the embryonic environment, Histogen has developed a human extracellular matrix (hECM) material composed of stem cell-associated proteins including SPARC, decorin, collagens I,III,IV, V, fibronectin, fibrillin, laminins, and hyaluronic acid. The hECM’s distinctive composition of growth factors and other proteins are known to stimulate stem cells in the body, regenerate tissues, and promote scarless healing. [Histogen, Inc.] Press Release

Life Stem Genetics Announces James Vanden Bosch as Chief Medical Stem Cell Specialist
Life Stem Genetics, Inc. announced that its Regenerative Specialist, James Vanden Bosch, BHA, has been given the title and responsibility of Chief Medical Stem Cell Specialist at Life Stem Genetics. [Business Wire] Press Release

From our sponsor:
Pluripotent cell isolation for regenerative medicine. Request a free wallchart from Nature.
Regenerative Medicine Certification System Eyed
The Japanese Society for Regenerative Medicine (JSRM) will establish a certification system for physicians with expertise and skills in regenerative medicine and for medical technicians adept at cell culturing techniques as early as next fall, JSRM officials said. [The Japan Times] Press Release

House Hearing Skates over Big Disagreements on NSF Reauthorization
Congressional hearings can sometimes hide more than they reveal. So it was, when the research panel of the U.S. House of Representatives science committee held its first public airing of a bill that would make some controversial changes to peer review at the National Science Foundation (NSF). [ScienceInsider] Editorial

Open-Access Group Sanctions Three Publishers after Science ‘Sting’
A leading trade association for the publishers of free, open-access scientific journals has expelled two of its members, and put a third on probation, as a result of a controversial investigative journalism project published earlier this year by Science. The Open Access Scholarly Publishers Association announced on its blog that it is terminating the memberships of publishers Hikari Ltd. and Dove Medical Press and placing the membership of SAGE Publications “under review” for six months. [ScienceInsider] Editorial
NEW 4th International Conference on Stem Cell Engineering
March 16-19, 2014
Coronado, United States

Visit our events page to see a complete list of events in the ESC & iPSC community.
NEW Research Associate – Stem Cells & Regenerative Medicine (King’s College London)

NEW Postdoctoral Fellow – Liver Tissue Engineering (Harvard Medical School)

PhD Studentship – Wnt-Signaling and Stem Cell Biology (University of Amsterdam)

Postdoctoral Position – Stem Cells and Epigenetics (Icahn School of Medicine at Mount Sinai)

Assistant Director (Wake Forest Institute for Regenerative Medicine)

Postdoctoral Position – Human Stem Cells (Sabine Costagliola-ULB)

Faculty Position – Stem Cell Biology (University of Notre Dame / College of Science)

Postdoctoral Associate – Human and Mouse Stem Cell Biology, Pancreatic and Liver Specification and In Vitro Disease Modeling (Baylor College of Medicine)

Postdoctoral Position – RNA & Stem Cell Biology (Cancer Research Centre of Lyon)

Postdoctoral Research Fellow – Stem Cells (Bioprocessing Technology Institute)

Scientist – Particle Chemistry (STEMCELL Technologies Inc.)

Research Technologist – Human Pluripotent Stem Cell Products (STEMCELL Technologies Inc.)

Research Associate/Scientist – Antibodies Group (STEMCELL Technologies Inc.)

Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.
Learn more about ESC & iPSC News: Archives | Events | Contact Us